The largest database of trusted experimental protocols

59 protocols using nlaiii

1

Single-cell genomic profiling of organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Organoids were dissociated into single cells with TrypLE (Gibco). After washout of TrypLE, cells were frozen in 500 mL of recovery cell culture freezing medium (Gibco) for subsequent sorting and sequencing. G1 single nuclei, identified by propidium iodide and Hoechst staining, were sorted into a 384-well plate with 10 mL of mineral oil (Sigma-Aldrich) in each well, and stored at À80 C. Cell lysis was carried out for 2 h at 50 C using Proteinase K (Ambion) in 1x Cutsmart (New England Biolabs), followed by heat inactivation at 80 C for 15 min. Genomic DNA was then fragmented with 100 nL of 1 U NlaIII (New England Biolabs) in 13 Cutsmart (New England Biolabs) for 2 h at 37 C, followed by heat inactivation at 65 C for 20 min. Next, the following was added to each well: (i) 50 nL containing 50 mM barcoded double-stranded NlaIII adapters; (ii) 150 nL of 13 T4 DNA ligase buffer containing 40 U T4 DNA ligase (New England Biolabs), supplemented with 10 mM ATP (Invitrogen). The mixture was ligated overnight at 16 C, after which samples were pooled. Libraries were sequenced on an Illumina Nextseq 2000 with 2 x 100/150-bp paired-end sequencing.
+ Open protocol
+ Expand
2

Chromosome Conformation Capture Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
4C sample preparation was performed as previously described by Splinter et al. using NlaIII (NEB) and Csp6I (Thermo)34 (link). Viewpoint primers were selected from a previously reported database35 (link).
Primers sequences were concatenated with Illumina compatible adapter sequences and unique barcodes and synthesized as Ultramer oligos (IDT). Final library amplification was set up on ice using 3.2 µg of purified 4C sample DNA, 2.5 µM primers, and Ultra II Q5 Master Mix (NEB) split into 16 × 50 µl PCR reactions with extension at 65 °C. Amplification products were purified using 1.5× Ampure XP (Beckman) bead purification. Size distributions were established using a Bioanalyzer DNA 12000 Assay (Agilent).
Paired-end sequencing reads were generated as above and analyzed with the 4C-ker pipeline as previously described to identify genomic loci with differential chromosome contacts between conditions36 (link).
+ Open protocol
+ Expand
3

Targeted Locus Amplification for T-ALL

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the preparation of patient samples and cell lines we made use of the Targeted Locus Amplification,82 (link) provided as a service by Cergentis BV, Utrecht, the Netherlands. We used the manufacturer’s protocol to prepare the samples.119 (link) Briefly, 5–10 million cells were cross-linked by adding 37% Formaldehyde to a final concentration of 1%. Cells were lysed and DNA was digested with NlaIII (New England Biolabs), followed by ligation with T4 DNA ligase. Following a crosslink removal step, the DNA was purified and digested using NspI (New England Biolabs) and ligated. The DNA was purified and a TLA PCR was performed with primers that were specifically designed for this study. The PCR product was purified by AMPure XP beads (Beckman Coulter, Brea, CA) and prepared for Next Generation Sequencing. Sequence data by Illumina MiSeq has been deposited at the Sequence Read Archive (SRA) (key resources table). The breakpoints of 3 T-ALL patients (#10929, #9319, #9452) have been determined before using Complete Genomics WGS sequencing platform120 (link) and are available from the European Nucleotide Archive database (http://www.ebi.ac.uk/ena) (key resources table). Breakpoint for the St Jude T-ALL patients have been determined by Illumina HiSeq 2000 WGS before,121 (link) and are accessible through the European Genome-phenomen Archive (key resources table).
+ Open protocol
+ Expand
4

Genetic Variations Analysis in CRC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from peripheral blood samples collected with an anticoagulant using a G-DEX blood extraction kit (iNtRON Biotechnology, Seongnam, South Korea). Nucleotide changes were determined via a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis. Restriction enzyme digestion was carried out using the following enzymes (New England BioLabs, Ipswich, MA): NlaIII (DROSHA, rs10719), BanI (DICER1, rs3742330), BslI (RAN, rs14035), and BsmI (XPO5, rs11077). Digestion was carried out at 37°C for 16 h.
Genotypes determined by RFLP analysis were confirmed by two independent investigators and by sequencing 10% of the samples. For RAN rs14035 in the control group and XPO5 rs11077 in CRC patients, genotypes were verified three times to rule out possible errors attributed to violation of Hardy-Weinberg equilibrium (HWE).
+ Open protocol
+ Expand
5

Profiling Genetic Variants in miRNA Biogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from peripheral blood samples collected with an anticoagulant using a G-DEX blood extraction kit (iNtRON Biotechnology, Seongnam, South Korea). Nucleotide changes were determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis. Restriction enzyme digestion was carried out using the following enzymes (New England BioLabs, Ipswich, MA, USA): BanI (DICER rs3742330), BccI (DICER rs13078), NlaIII (DROSHA, rs10719), Sau96I (DROSHA rs6877842), BslI (RAN, rs14035), and BsmI (XPO5, rs11077). Digestion was carried out at 37°C for 16 h.
Genotypes determined by RFLP analysis were confirmed by two independent investigators and by sequencing 10% of the samples.
+ Open protocol
+ Expand
6

A20 Regulation of NF-κB Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-FLAG antibody was purchased from Sigma (St. Louis, MO); anti-HA and anti-phospho-IκBα antibodies were purchased from Cell Signaling (Danvers, MA); anti-β-actin antibody was purchased from Abcam (Cambridge, MA); anti-A20 antibody was purchased from Ebioscience (San Diego, CA). HEK293T cell line was purchased and maintained per instructions from American Type Culture Collection (ATCC; Manassas, VA). Golden Gate cloning kit and expression vectors, pCS2TAL3DD and pCS2TAL3RR, were purchased from Addgene (Cambridge, MA). DH5α competent cells were purchased from Life Technologies (Grand Island, NY). QuantiTect SYBR Green PCR Master Mix was purchased from QIAGEN (Valencia, CA). Restriction enzymes NlaIII, EcoRV, and NEB Standard Buffer 4 were purchased from New England Biolabs (Ipswich, MA).
+ Open protocol
+ Expand
7

LAM-PCR Analysis of Engrafted Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was purified individually from human myeloid and lymphoid cells engrafted in mice. LAM-PCR analysis was performed as described previously.17 (link) Vector LTR junction sequences were amplified by linear PCR using 300 ng of genomic DNA, vector LTR–specific 5′ biotinylated primer, 5′-AGAACCTTGTGTCTCTCATCCC-3′, and PCR master mix. DNA was denatured at 94 °C for 5 minutes, followed by 50 cycles of amplification (94 °C for 45 seconds, 60 °C for 45 seconds, and 72 °C for 60 seconds), and a final extension at 72 °C for 10 minutes. Biotinylated PCR products were bound to streptavidin-conjugated magnetic beads overnight with mild shaking. After washing, double-stranded DNA was synthesized using a random hexamer (Invitrogen) and DNA polymerase I large fragment (NEB, Ipswich, MA). DNA was digested with MluCI, MseI, and NlaIII (NEB) and ligated to restriction enzyme-specific double-stranded linkers using the Quick Ligation Kit (NEB). DNA was denatured with 0.1 N NaOH and was PCR-amplified using LTR- and linker-specific primers (first nested PCR primer of LTR, 5′-ACCTCCTTCCCTGTAATACTC-3′, and primer of linker, 5′-GCACTCGTGCTCGACTGATAC-3′; second nested PCR primer of LTR, 5′-CCTGGTTTCTAGTGGCATTC-3′ and primer of linker, 5′-CCGTCGTATCGTAGCACAG-3′). A schematic diagram shows the LAM-PCR analysis (see Supplementary Figure S4).
+ Open protocol
+ Expand
8

Genotyping of Common Genetic Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from 200 μL of peripheral blood using a standard Qiagen DNA blood mini kit (Valencia, CA, USA) according to the manufacturer’s protocol. The SNPs at positions -22 (C > G) (rs2239527; G ancestral allele) and -348 (C > T) (rs2239528 ;C ancestral allele) in the promoter region of DDX39B and at position -176 of IL6 (G > C) (rs2234683; G ancestral allele) were typed using PCR restriction fragment-length polymorphism analysis with the restriction enzyme NlaIII (New England Biolabs), according to protocols previously published by Ramasawmy et al.[25 (link)] and Yalcin et al.[26 (link)], respectively. TNF-308 (G > A) (rs1800629; G ancestral allele) polymorphism was also evaluated using PCR restriction fragment-length polymorphism analysis with the restriction enzyme NcoI (New England Biolabs), as published previously [27 (link)]. DDX39B and TNF PCR products were electrophoresed on 10% polyacrylamide gels and IL6 products were separated by electrophoresis on 1% agarose gels under nondenaturing conditions. The PCR products were then detected by staining with ethidium bromide and visualized under ultraviolet illumination.
+ Open protocol
+ Expand
9

Efficient Single-Stranded DNA Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
dsDNA was prepared with two-step PCR. The first-round PCR was performed using non-modified primers followed by treatment with DpnI and exonuclease I, as described above. The specific PCR product was gel purified and then used as a template for the second-round PCR with two short primers (about 25 nt), one of which contains five sequential PS bonds at the 5’ end. After column purification, the dsDNA was reacted with T7 exonuclease as described above. For the preparation of T7RE donors, HpyCH4III (0.025 U/µL), Hpy188I (0.1 U/µL), NlaIII (0.025 U/µL), and RsaI (0.05 U/µL) purchased from New England Biolabs were added directly to the T7 exonuclease reaction mix and incubated at 37 °C for 15 min. After the enzymatic reactions, ssDNA was column-purified using Buffer NTC (Macherey–Nagel) as a binding buffer. Typically, 4 to 5 µg of ssDNA was obtained from 15 µg of dsDNA, when elution with 15 µL of nuclease-free water was conducted twice.
+ Open protocol
+ Expand
10

IL-6 Gene Polymorphism Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard EDTA tubes were used to obtain blood samples, and DNA was obtained from each patient’s white blood cells using the QIAmp® DNA Blood Mini Kit. The blood samples were collected from patients during clinical evaluation. The DNA was extracted and analyzed by polymerase chain reaction (PCR) assay during the patient’s evaluation. After restriction fragment length polymorphism processing, IL-6 −174G/C polymorphism was analyzed using PCR (Figure 1). The primers for polymorphism analysis was used with the standard primers. Digest 164 bp products of PCR was completed at the condition of 5 units NlaIII (New England Biolabs) at 37°C for 4 hours. Restriction fragments were analyzed using 3% ethidium bromide-stained agarose gel. The 111- and 52-position fragments are consistent with the homozygous genotype C/C; 164 bp represents the homozygous genotype G/G. The three fragments in the positions of 111, 52, and 164 bp represent the heterozygous genotype G/C. The reliability of samples was analyzed and evaluated. A negative control was used to prevent false positive results.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!